Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knut Woltjen

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Stem Cell Reports|January 15, 2019
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming IntermediatesHarunobu Kagawa, Ren Shimamoto, Shin-Il Kim, et al.
Nature Communications|April 19, 2023
Programmable mammalian translational modulators by CRISPR-associated proteinsShunsuke Kawasaki, Hiroki Ono, Moe Hirosawa, et al.
Cancer Science|December 28, 2018
Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modelingNorihide Jo, Yuko Sogabe, Yosuke Yamada, et al.
Nucleic Acids Research|May 20, 2017
Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switchMoe Hirosawa, Yoshihiko Fujita, Callum J C Parr, et al.
Communications Biology|March 24, 2026
Optimizing CRISPR precision in mouse embryos via microhomology-mediated end joining-dominant targetingKhanui Lkhagvadorj, Eiichi Okamura, Taito Taki, et al.
Cell Reports Methods|April 27, 2022
A stress-reduced passaging technique improves the viability of human pluripotent cellsKazutoshi Takahashi, Chikako Okubo, Michiko Nakamura, et al.
Stem Cell Reports|August 18, 2015
Reprogramming Roadblocks Are System DependentEleni Chantzoura, Stavroula Skylaki, Sergio Menendez, et al.
Biochemical and Biophysical Research Communications|January 15, 2013
Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cellsKazuo Hayakawa, Makoto Ikeya, Makoto Fukuta, et al.
Stem Cell Reports|March 17, 2015
KLF4 N-terminal variance modulates induced reprogramming to pluripotencyShin-Il Kim, Fabian Oceguera-Yanez, Ryoko Hirohata, et al.
Stem Cell Reports|March 22, 2016
An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma DevelopmentShingo Komura, Katsunori Semi, Fumiaki Itakura, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Stem Cell Reports|January 15, 2019
OVOL1 Influences the Determination and Expansion of iPSC Reprogramming IntermediatesHarunobu Kagawa, Ren Shimamoto, Shin-Il Kim, et al.
Nature Communications|April 19, 2023
Programmable mammalian translational modulators by CRISPR-associated proteinsShunsuke Kawasaki, Hiroki Ono, Moe Hirosawa, et al.
Cancer Science|December 28, 2018
Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modelingNorihide Jo, Yuko Sogabe, Yosuke Yamada, et al.
Nucleic Acids Research|May 20, 2017
Cell-type-specific genome editing with a microRNA-responsive CRISPR-Cas9 switchMoe Hirosawa, Yoshihiko Fujita, Callum J C Parr, et al.
Communications Biology|March 24, 2026
Optimizing CRISPR precision in mouse embryos via microhomology-mediated end joining-dominant targetingKhanui Lkhagvadorj, Eiichi Okamura, Taito Taki, et al.
Cell Reports Methods|April 27, 2022
A stress-reduced passaging technique improves the viability of human pluripotent cellsKazutoshi Takahashi, Chikako Okubo, Michiko Nakamura, et al.
Stem Cell Reports|August 18, 2015
Reprogramming Roadblocks Are System DependentEleni Chantzoura, Stavroula Skylaki, Sergio Menendez, et al.
Biochemical and Biophysical Research Communications|January 15, 2013
Identification of target genes of synovial sarcoma-associated fusion oncoprotein using human pluripotent stem cellsKazuo Hayakawa, Makoto Ikeya, Makoto Fukuta, et al.
Stem Cell Reports|March 17, 2015
KLF4 N-terminal variance modulates induced reprogramming to pluripotencyShin-Il Kim, Fabian Oceguera-Yanez, Ryoko Hirohata, et al.
Stem Cell Reports|March 22, 2016
An EWS-FLI1-Induced Osteosarcoma Model Unveiled a Crucial Role of Impaired Osteogenic Differentiation on Osteosarcoma DevelopmentShingo Komura, Katsunori Semi, Fumiaki Itakura, et al.
Pageof 8